Task: Answer Verification
Input (English): Question: Is canonical androstenedione reduction the predominant source of signaling androgens in hormone-refractory prostate cancer?
Answer: Reduction of androstenedione to testosterone by the canonical HSD17B AKR1C3 is the predominant source of signaling androgens in HRPC.
Output (English): yes